BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
IL1A
,
Response to oxidative stress
,
Influenza
,
Neuron
,
Biofuel
,
Phenobarbital
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Tivozanib
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
AGR2
CRIP1
SERPINA3
HBB
LCN2
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
cytosol
organic cyclic compound binding
regulation of nitrogen compound metabolic process
heterocyclic compound binding
cell periphery
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
L1000 CMAP - Motor neuron MNEU.E cells treated with small molecule perturbagens
L1000 CMAP - Embryonic stem HUES3 cells treated with small molecule perturbagens
L1000 CMAP - Umbilical vein endothelial HUVEC cells treated with small molecule perturbagens
L1000 CMAP - Neuronal NEU cells treated with small molecule perturbagens
L1000 CMAP - Skeletal muscle SKL.C cells treated with small molecule perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
HPLC methods for studying pharmacokinetics of tivozanib and in vitro metabolic interaction with dexa…
Clinical Outcomes of Tivozanib Monotherapy as First-Line Treatment for Metastatic Renal Cell Carcino…
Efficacy, Safety, and Tolerability of Tivozanib in Heavily Pretreated Patients With Advanced Clear C…
Tivozanib in Patients with Advanced Renal Cell Carcinoma Previously Treated With Axitinib: Subgroup …
Tivozanib: A New Hope for Treating Renal Cell Carcinoma.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Tivozanib + Gemcitabine in Metastatic RCC
Tivozanib As Maintenance Therapy In GYN
Evaluating Safety and Efficacy of Tivozanib (AV-951) in Cholangiocarcinoma
A Rollover Protocol to Allow Continued Access to Tivozanib (AV 951) for Subjects Enrolled in Other T…
Tivozanib for Recurrent Glioblastoma
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ